-
Je něco špatně v tomto záznamu ?
Partial upper sternotomy for aortic valve replacement provides similar mid-term outcomes as the full sternotomy
J. Hlavicka, D. Janda, P. Budera, P. Tousek, M. Maly, R. Fojt, H. Linkova, T. Holubec, P. Kacer
Jazyk angličtina Země Čína
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
PubMed
35572904
DOI
10.21037/jtd-21-1494
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background: Minimally invasive aortic valve replacement via upper partial sternotomy (MiniAVR) provides very good short-term results and delivers certain advantages in the postoperative course. There is limited data regarding the mid-term mortality and morbidity following this minimally invasive surgery. Methods: We provide a retrospective analysis of the patients, undergoing MiniAVR versus full sternotomy (FS) for aortic valve replacement with biological prosthesis. As the primary combined end-point the combination of death, stroke, and rehospitalization within 3 years postoperatively was defined. Data have been collected from National Cardiac Surgery Registry and insurance companies. Results: Two hundred consecutive patients with aortic valve replacement (100 ministernotomy in MiniAVR group and 100 full sternotomy in FS group) with biological prosthesis were included in this study. Ministernotomy had longer cross-clamp and bypass times (median difference 6.5 min, P=0.005, and 8.5 min, P=0.002 respectively). Patients operated via upper partial sternotomy had a lower postoperative bleeding [300 mL (IQR, 290) vs. 365 mL (IQR, 207), P=0.031]. There was no difference in the 3-year mortality (14% vs. 11%, P=0.485). The mean number of readmission 3 years after surgery per capita was almost the same in both groups (1.65 vs. 1.60, P=0.836). Median time to the first readmission was longer in the MiniAVR group (difference 8.9 months). The incidence of combined end-point during 3 years postoperatively in both groups was not statistically different (P=0.148), as well as readmissions from cardio-vascular reasons (subhazard ratio 0.90, P=0.693). Conclusions: Upper partial sternotomy can be performed safely for aortic valve replacement, without increased risk of death, stroke or re-admission in 3 years postoperatively.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017459
- 003
- CZ-PrNML
- 005
- 20220720100233.0
- 007
- ta
- 008
- 220718s2022 cc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21037/jtd-21-1494 $2 doi
- 035 __
- $a (PubMed)35572904
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a cc
- 100 1_
- $a Hlavicka, Jan $u Department of Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 245 10
- $a Partial upper sternotomy for aortic valve replacement provides similar mid-term outcomes as the full sternotomy / $c J. Hlavicka, D. Janda, P. Budera, P. Tousek, M. Maly, R. Fojt, H. Linkova, T. Holubec, P. Kacer
- 520 9_
- $a Background: Minimally invasive aortic valve replacement via upper partial sternotomy (MiniAVR) provides very good short-term results and delivers certain advantages in the postoperative course. There is limited data regarding the mid-term mortality and morbidity following this minimally invasive surgery. Methods: We provide a retrospective analysis of the patients, undergoing MiniAVR versus full sternotomy (FS) for aortic valve replacement with biological prosthesis. As the primary combined end-point the combination of death, stroke, and rehospitalization within 3 years postoperatively was defined. Data have been collected from National Cardiac Surgery Registry and insurance companies. Results: Two hundred consecutive patients with aortic valve replacement (100 ministernotomy in MiniAVR group and 100 full sternotomy in FS group) with biological prosthesis were included in this study. Ministernotomy had longer cross-clamp and bypass times (median difference 6.5 min, P=0.005, and 8.5 min, P=0.002 respectively). Patients operated via upper partial sternotomy had a lower postoperative bleeding [300 mL (IQR, 290) vs. 365 mL (IQR, 207), P=0.031]. There was no difference in the 3-year mortality (14% vs. 11%, P=0.485). The mean number of readmission 3 years after surgery per capita was almost the same in both groups (1.65 vs. 1.60, P=0.836). Median time to the first readmission was longer in the MiniAVR group (difference 8.9 months). The incidence of combined end-point during 3 years postoperatively in both groups was not statistically different (P=0.148), as well as readmissions from cardio-vascular reasons (subhazard ratio 0.90, P=0.693). Conclusions: Upper partial sternotomy can be performed safely for aortic valve replacement, without increased risk of death, stroke or re-admission in 3 years postoperatively.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Janda, David $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Budera, Petr $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Tousek, Petr $u Department of Cardiology, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Maly, Marek $u National Institute of Public Health, Prague, Czech Republic
- 700 1_
- $a Fojt, Richard $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Linkova, Hana $u Department of Cardiology, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Holubec, Tomas $u Department of Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
- 700 1_
- $a Kacer, Petr $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00194907 $t Journal of thoracic disease $x 2072-1439 $g Roč. 14, č. 4 (2022), s. 857-865
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35572904 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100228 $b ABA008
- 999 __
- $a ind $b bmc $g 1816597 $s 1168701
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 14 $c 4 $d 857-865 $e - $i 2072-1439 $m Journal of thoracic disease $n J Thorac Dis $x MED00194907
- LZP __
- $a Pubmed-20220718